XRT secures new investors

By Helen Schuller
Monday, 29 August, 2005

Unlisted imaging company XRT, an investee of BioTech Capital (ASX:BTC), has secured new investment funds from a syndicate of UK investors including an undisclosed institutional group.

Total funds to be invested in XRT equate to approximately £1.5 million (AUD$3.8million) at a pre-money valuation of £7.1 million.

Melbourne based XRT is planning to relocate its business development activities to the UK and will use the funds for the recruitment of a UK-based senior management team and to execute its business plan.

Related News

More effective antibiotic found for Lyme disease

Researchers have found that piperacillin, an antibiotic in the same class as penicillin,...

Why do our waistlines expand in middle age?

A new preclinical study highlights the importance of controlling new fat-cell formation to...

Anti-inflammatory drug may help treat alcohol use disorder

A drug that is already FDA-approved for treating inflammatory conditions may help reduce both...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd